High rates of hepatitis B vertical transmission in Kiribati: a warning sign for meeting 2030 WHO elimination targets in the Pacific Islands?
World Health Organization (WHO) goals for 2030 include a 90% reduction in new cases of hepatitis B (HBV) and a prevalence of less than 0.1% in children by 2030.1 The key to meeting these goals is the prevention of mother to child transmission of HBV (PMTCT). Hepatitis B immunoglobulin administration is impractical in most Pacific Island countries and territories (PICTs) due to its cost, storage requirements, and distribution challenges. Therefore, HBV birth dose vaccination (BDV) and anti-viral prophylaxis in HBV-positive pregnant women remain the two pillars of PMTCT.
Authors
- David C. Hilmers (ORCID: https://orcid.org/0000-0001-6176-0132)
- Thomas M. Russell
- Alice Lee (ORCID: https://orcid.org/0000-0003-0188-0612)
Institutions
- The University of Sydney (AU)
- Baylor College of Medicine (US)
- Concord Repatriation General Hospital (AU)
- Ministry of Fisheries and Marine Resource Development (KI)
Publication Details
- Journal
- The Lancet Regional Health - Western Pacific
- Published
- 2025-07-01
- DOI
- https://doi.org/10.1016/j.lanwpc.2025.101624
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00